Born in Germany’s high-tech skincare ecosystem, My Clea unites dermatologists, biochemists and aesthetic physicians to unlock every skin’s potential through evidence-based beauty.
Vision
To become the global reference for science-first, results-driven skincare that removes the need for corrective aesthetics.
Mission
To craft high-performance, nature-inspired formulas with the purest actives at dermatologically-proven concentrations-delivering visible, trustworthy and inclusive results for every skin type.
From molecule screening to multi-phase patch tests, every step is run under German lab standards to ensure actives reach the exact skin depth where renewal begins.
Clinical-Level Concentration
We use the highest percentage proven safe in peerreviewed studies-calibrated for penetration-so visible change starts within one epidermal cycle.
Clean & Compatible
Zero parabens, micro-plastics or dyes; dermatologically tested even on sensitive, post-procedure skin.
Sustainable Ethics
Botanicals are responsibly cultivated, biotech actives are fermentation-derived, and all formulas are vegan & cruelty-free.
Future Vision
Pipeline 2025-2027
Gene-Lipid Serums – mRNA-friendly lipopeptides that upregulate filaggrin for atopy-prone skin
Microbiome-Mood Actives – post-biotic lysates shown to boost ẞ-endorphin +18%, calming both barrier & mind
Photo-Programmable Cream – light-activated capsule releases extra retinol only under blue-light exposure (officescreen defense)
Green Chemistry Leap
Carbon-negative fermentation (sugar-beet feedstock) for hyaluronic & ceramide precursors – pilot plant online 2026
100% mono-material refill pods – drop-in replacement, zero tool change for consumer
Digital Derm Companion
Al patch-camera reads transepidermal water-loss & melanin index → recommends daily dose; data stored under GDPRencrypted EU cloud
Auto-replenish subscription synced to actual usage, not calendar
Global Footprint
Entry into Nordics & APAC clinics via tele-derm partnerships; localized formulas for UV-intense, high-humidity climates Target: 3 x revenue by 2030 while maintaining < 1 % returnrate (quality KPI)